• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工转录因子的蛋白质递送可恢复天使综合征小鼠大脑中广泛的Ube3a表达。

Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.

作者信息

Bailus Barbara J, Pyles Benjamin, McAlister Michelle M, O'Geen Henriette, Lockwood Sarah H, Adams Alexa N, Nguyen Jennifer Trang T, Yu Abigail, Berman Robert F, Segal David J

机构信息

Genome Center, MIND Institute, and Department of Biochemistry and Molecular Medicine, University of California, Davis, California, USA.

Department of Neurological Surgery, University of California, Davis, California, USA.

出版信息

Mol Ther. 2016 Mar;24(3):548-55. doi: 10.1038/mt.2015.236. Epub 2016 Jan 4.

DOI:10.1038/mt.2015.236
PMID:26727042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4786922/
Abstract

Angelman syndrome (AS) is a neurological genetic disorder caused by loss of expression of the maternal copy of UBE3A in the brain. Due to brain-specific genetic imprinting at this locus, the paternal UBE3A is silenced by a long antisense transcript. Inhibition of the antisense transcript could lead to unsilencing of paternal UBE3A, thus providing a therapeutic approach for AS. However, widespread delivery of gene regulators to the brain remains challenging. Here, we report an engineered zinc finger-based artificial transcription factor (ATF) that, when injected i.p. or s.c., crossed the blood-brain barrier and increased Ube3a expression in the brain of an adult mouse model of AS. The factor displayed widespread distribution throughout the brain. Immunohistochemistry of both the hippocampus and cerebellum revealed an increase in Ube3a upon treatment. An ATF containing an alternative DNA-binding domain did not activate Ube3a. We believe this to be the first report of an injectable engineered zinc finger protein that can cause widespread activation of an endogenous gene in the brain. These observations have important implications for the study and treatment of AS and other neurological disorders.

摘要

天使综合征(AS)是一种神经遗传性疾病,由大脑中母本UBE3A基因拷贝的表达缺失引起。由于该基因座存在脑特异性基因印记,父本UBE3A被一个长反义转录本沉默。抑制该反义转录本可导致父本UBE3A去沉默,从而为AS提供一种治疗方法。然而,将基因调控因子广泛递送至大脑仍然具有挑战性。在此,我们报道了一种基于锌指的工程化人工转录因子(ATF),当通过腹腔注射或皮下注射时,其能够穿过血脑屏障并增加成年AS小鼠模型大脑中Ube3a的表达。该因子在整个大脑中广泛分布。海马体和小脑的免疫组织化学显示,治疗后Ube3a表达增加。含有替代DNA结合结构域的ATF不能激活Ube3a。我们认为这是关于一种可注射的工程化锌指蛋白能够在大脑中广泛激活内源性基因的首次报道。这些发现对AS及其他神经疾病的研究和治疗具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/583eb54c1d14/mt2015236f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/2ad64015443e/mt2015236f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/96d77dfa55e6/mt2015236f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/036b3ee927e3/mt2015236f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/583eb54c1d14/mt2015236f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/2ad64015443e/mt2015236f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/96d77dfa55e6/mt2015236f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/036b3ee927e3/mt2015236f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302e/4786922/583eb54c1d14/mt2015236f4.jpg

相似文献

1
Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.人工转录因子的蛋白质递送可恢复天使综合征小鼠大脑中广泛的Ube3a表达。
Mol Ther. 2016 Mar;24(3):548-55. doi: 10.1038/mt.2015.236. Epub 2016 Jan 4.
2
Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model.转录重编程在 Angelman 综合征小鼠模型中恢复了 UBE3A 在大脑中的广泛表达,并挽救了行为表型。
Mol Ther. 2023 Apr 5;31(4):1088-1105. doi: 10.1016/j.ymthe.2023.01.013. Epub 2023 Jan 14.
3
CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.CRISPR/Cas9 靶向 Ube3a 反义转录本可改善小鼠的 Angelman 综合征表型。
J Clin Invest. 2021 Mar 1;131(5). doi: 10.1172/JCI142574.
4
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.通过靶向长非编码 RNA 治疗 Angelman 综合征。
Nature. 2015 Feb 19;518(7539):409-12. doi: 10.1038/nature13975. Epub 2014 Dec 1.
5
Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.UBE3A-ATS 截短使父源 UBE3A 去沉默化,并改善 Angelman 综合征小鼠模型的行为缺陷。
PLoS Genet. 2013;9(12):e1004039. doi: 10.1371/journal.pgen.1004039. Epub 2013 Dec 26.
6
Ube3a unsilencer for the potential treatment of Angelman syndrome.UBE3A 去沉默化治疗 Angelman 综合征的潜在方法。
Nat Commun. 2024 Jul 8;15(1):5558. doi: 10.1038/s41467-024-49788-8.
7
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.在啮齿动物和 Angelman 综合征小鼠模型中 Ube3a 蛋白表达的组织特异性变化。
Neurobiol Dis. 2010 Sep;39(3):283-91. doi: 10.1016/j.nbd.2010.04.012. Epub 2010 Apr 25.
8
Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.UBE3A 缺失对突触基因网络和 Wnt 信号通路的印迹效应。
Hum Mol Genet. 2019 Nov 15;28(22):3842-3852. doi: 10.1093/hmg/ddz221.
9
Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndrome.吲哚异喹啉类拓扑异构酶 I 抑制剂的鉴定及构效关系研究及其在沉默与 Angelman 综合征相关的休眠基因中的应用。
Mol Autism. 2018 Aug 17;9:45. doi: 10.1186/s13229-018-0228-2. eCollection 2018.
10
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.R 环在 Snord116 处的形成介导拓扑替康抑制 Ube3a-反义链和等位基因特异性染色质去凝聚。
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13938-43. doi: 10.1073/pnas.1305426110. Epub 2013 Aug 5.

引用本文的文献

1
AAV-dCas9 vector unsilences paternal Ube3a in neurons by impeding Ube3a-ATS transcription.腺相关病毒-dCas9载体通过阻碍Ube3a-ATS转录使神经元中父本来源的Ube3a去沉默。
Commun Biol. 2025 Sep 2;8(1):1332. doi: 10.1038/s42003-025-08794-2.
2
Vector-free intra-airway in vivo epigenetic editing.无载体气道内体内表观遗传编辑。
Trends Biotechnol. 2025 Jun 9. doi: 10.1016/j.tibtech.2025.05.007.
3
Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome.

本文引用的文献

1
Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity.合成表观遗传学——朝向对表观遗传状态和细胞身份的智能控制。
Clin Epigenetics. 2015 Mar 4;7(1):18. doi: 10.1186/s13148-015-0044-x. eCollection 2015.
2
Epigenome engineering in cancer: fairytale or a realistic path to the clinic?癌症中的表观基因组工程:童话还是通往临床的现实途径?
Front Oncol. 2015 Feb 6;5:22. doi: 10.3389/fonc.2015.00022. eCollection 2015.
3
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.通过靶向长非编码 RNA 治疗 Angelman 综合征。
在天使综合征小鼠模型中,急性给予洛伐他汀对运动能力、运动协调性、步态或简单认知均无显著影响。
J Neurodev Disord. 2025 May 17;17(1):27. doi: 10.1186/s11689-025-09616-6.
4
Emerging Trends and Hot Spots in Epigenetic Modifications in Neurology: A Bibliometric Analysis.神经学中表观遗传修饰的新兴趋势与热点:文献计量分析
Mol Neurobiol. 2025 Apr 11. doi: 10.1007/s12035-025-04862-0.
5
Courtship and distress ultrasonic vocalizations are disrupted in a mouse model of Angelman syndrome.在天使综合征小鼠模型中,求偶和应激性超声发声受到干扰。
Res Sq. 2025 Feb 11:rs.3.rs-5953744. doi: 10.21203/rs.3.rs-5953744/v1.
6
Development of compact transcriptional effectors using high-throughput measurements in diverse contexts.利用不同环境下的高通量测量开发紧凑型转录效应器。
Nat Biotechnol. 2024 Nov 1. doi: 10.1038/s41587-024-02442-6.
7
Development of artificial transcription factors and their applications in cell reprograming, genetic screen, and disease treatment.人工转录因子的开发及其在细胞重编程、基因筛选和疾病治疗中的应用。
Mol Ther. 2024 Dec 4;32(12):4208-4234. doi: 10.1016/j.ymthe.2024.10.029. Epub 2024 Oct 28.
8
Neuroepigenetic Editing.神经表观遗传学编辑。
Methods Mol Biol. 2024;2842:129-152. doi: 10.1007/978-1-0716-4051-7_6.
9
A Directed Evolution Protocol for Engineering Minimal Transcription Factors, Based on CIS Display.基于 CIS 展示的工程最小转录因子的定向进化协议。
Methods Mol Biol. 2024;2774:1-13. doi: 10.1007/978-1-0716-3718-0_1.
10
UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.泛素蛋白连接酶E3A:在自闭症谱系障碍(ASD)中的作用以及生物标志物研究和治疗策略设计的潜在候选物
Diseases. 2023 Dec 27;12(1):7. doi: 10.3390/diseases12010007.
Nature. 2015 Feb 19;518(7539):409-12. doi: 10.1038/nature13975. Epub 2014 Dec 1.
4
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.阳离子脂质介导的蛋白质递送能够在体外和体内实现高效的基于蛋白质的基因组编辑。
Nat Biotechnol. 2015 Jan;33(1):73-80. doi: 10.1038/nbt.3081. Epub 2014 Oct 30.
5
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.全基因组规模的CRISPR介导的基因抑制与激活控制
Cell. 2014 Oct 23;159(3):647-61. doi: 10.1016/j.cell.2014.09.029. Epub 2014 Oct 9.
6
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders.用于治疗 Angelman 综合征和其他单基因神经疾病的分子治疗前景。
BMC Neurosci. 2014 Jun 19;15:76. doi: 10.1186/1471-2202-15-76.
7
A 21st-century approach to age-old problems: the ascension of biologics in clinical therapeutics.21 世纪解决古老问题的方法:生物制剂在临床治疗中的兴起。
Drug Discov Today. 2014 Aug;19(8):1109-13. doi: 10.1016/j.drudis.2014.01.008. Epub 2014 Jan 27.
8
Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering.通过生物共轭作用,利用细胞穿透肽介导TALEN蛋白递送用于基因组工程。
PLoS One. 2014 Jan 20;9(1):e85755. doi: 10.1371/journal.pone.0085755. eCollection 2014.
9
Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.UBE3A-ATS 截短使父源 UBE3A 去沉默化,并改善 Angelman 综合征小鼠模型的行为缺陷。
PLoS Genet. 2013;9(12):e1004039. doi: 10.1371/journal.pgen.1004039. Epub 2013 Dec 26.
10
RNAs of the human chromosome 15q11-q13 imprinted region.人类 15q11-q13 印记区域的 RNA。
Wiley Interdiscip Rev RNA. 2013 Mar-Apr;4(2):155-66. doi: 10.1002/wrna.1150. Epub 2012 Dec 3.